In December, Baudax Bio filed a notice with the SEC stating that its financial struggles “raise substantial doubt about [the company’s] ability to continue as a going concern.”
John George
Source link
In December, Baudax Bio filed a notice with the SEC stating that its financial struggles “raise substantial doubt about [the company’s] ability to continue as a going concern.”
John George
Source link